132 related articles for article (PubMed ID: 15244111)
1. [Neuroprotective effects of topiramate].
Pappalardo A; Liberto A; Patti F; Reggio A
Clin Ter; 2004; 155(2-3):75-8. PubMed ID: 15244111
[TBL] [Abstract][Full Text] [Related]
2. Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures.
Angehagen M; Rönnbäck L; Hansson E; Ben-Menachem E
J Neurochem; 2005 Aug; 94(4):1124-30. PubMed ID: 16092949
[TBL] [Abstract][Full Text] [Related]
3. Involvement of AMPA/kainate and GABAA receptors in topiramate neuroprotective effects against methylphenidate abuse sequels involving oxidative stress and inflammation in rat isolated hippocampus.
Motaghinejad M; Motevalian M
Eur J Pharmacol; 2016 Aug; 784():181-91. PubMed ID: 27105819
[TBL] [Abstract][Full Text] [Related]
4. Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.
Shank RP; Maryanoff BE
CNS Neurosci Ther; 2008; 14(2):120-42. PubMed ID: 18482025
[TBL] [Abstract][Full Text] [Related]
5. Synergism between topiramate and budipine in refractory status epilepticus in the rat.
Fisher A; Wang X; Cock HR; Thom M; Patsalos PN; Walker MC
Epilepsia; 2004 Nov; 45(11):1300-7. PubMed ID: 15509230
[TBL] [Abstract][Full Text] [Related]
6. BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.
Weiser T; Brenner M; Palluk R; Bechtel WD; Ceci A; Brambilla A; Ensinger HA; Sagrada A; Wienrich M
J Pharmacol Exp Ther; 1999 Jun; 289(3):1343-9. PubMed ID: 10336525
[TBL] [Abstract][Full Text] [Related]
7. Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal-astroglial cultures.
Angehagen M; Ben-Menachem E; Rönnbäck L; Hansson E
Epilepsy Res; 2003 Apr; 54(1):63-71. PubMed ID: 12742598
[TBL] [Abstract][Full Text] [Related]
8. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.
Shank RP; Gardocki JF; Streeter AJ; Maryanoff BE
Epilepsia; 2000; 41(S1):3-9. PubMed ID: 10768292
[TBL] [Abstract][Full Text] [Related]
9. Topiramate mitigates 3-nitropropionic acid-induced striatal neurotoxicity via modulation of AMPA receptors.
Shalaby HN; El-Tanbouly DM; Zaki HF
Food Chem Toxicol; 2018 Aug; 118():227-234. PubMed ID: 29753867
[TBL] [Abstract][Full Text] [Related]
10. [Target pharmacology of topiramate, a new antiepileptic drug].
Nakamura J; Kuwana Y; Yukitoshi N
Nihon Yakurigaku Zasshi; 2000 Jan; 115(1):53-7. PubMed ID: 10876816
[TBL] [Abstract][Full Text] [Related]
11. Mediatory role of NMDA, AMPA/kainate, GABA
Motaghinejad M; Motevalian M; Fatima S
Life Sci; 2017 Jun; 179():37-53. PubMed ID: 28082019
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury.
Liu C; Lin N; Wu B; Qiu Y
Brain Res; 2009 Jul; 1282():173-82. PubMed ID: 19501064
[TBL] [Abstract][Full Text] [Related]
13. Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice.
Shi JQ; Wang BR; Tian YY; Xu J; Gao L; Zhao SL; Jiang T; Xie HG; Zhang YD
CNS Neurosci Ther; 2013 Nov; 19(11):871-81. PubMed ID: 23889921
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats.
Noh MR; Kim SK; Sun W; Park SK; Choi HC; Lim JH; Kim IH; Kim HJ; Kim H; Eun BL
Exp Neurol; 2006 Oct; 201(2):470-8. PubMed ID: 16884714
[TBL] [Abstract][Full Text] [Related]
15. Topiramate via NMDA, AMPA/kainate, GABA
Motaghinejad M; Motevalian M; Fatima S; Beiranvand T; Mozaffari S
J Neural Transm (Vienna); 2017 Nov; 124(11):1369-1387. PubMed ID: 28795276
[TBL] [Abstract][Full Text] [Related]
16. Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians.
Rawls SM; Thomas T; Adeola M; Patil T; Raymondi N; Poles A; Loo M; Raffa RB
Pharmacol Biochem Behav; 2009 Oct; 93(4):363-7. PubMed ID: 19447129
[TBL] [Abstract][Full Text] [Related]
17. Topiramate protects against glutamate excitotoxicity via activating BDNF/TrkB-dependent ERK pathway in rodent hippocampal neurons.
Mao XY; Cao YG; Ji Z; Zhou HH; Liu ZQ; Sun HL
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul; 60():11-7. PubMed ID: 25661849
[TBL] [Abstract][Full Text] [Related]
18. Concentration-effect studies with topiramate on selected enzymes and intermediates of the GABA shunt.
Sills GJ; Leach JP; Kilpatrick WS; Fraser CM; Thompson GG; Brodie MJ
Epilepsia; 2000; 41(S1):30-4. PubMed ID: 10768297
[TBL] [Abstract][Full Text] [Related]
19. Topiramate prevents excitotoxic damage in the newborn rodent brain.
Sfaello I; Baud O; Arzimanoglou A; Gressens P
Neurobiol Dis; 2005 Dec; 20(3):837-48. PubMed ID: 16009561
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics and indications of topiramate].
Nieto-Barrera M
Rev Neurol; 2002 Sep; 35 Suppl 1():S88-95. PubMed ID: 12373660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
